Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Patients With Primary Progressive Multiple Sclerosis
Location: REDI (East Bay); Sutter East Bay Medical Foundation
Please contact: Canary Jumawan about GN41791
Principal Investigator
Joanna A. Cooper, M.D., David Eric Collins, MD
Co-Investigator(s)
Aryn Earnhardt, NP, Bradley T Wrubel, MD, Lynn Jehle, NP, Matthew W. Arnold, M.D., Antonio J Silva-Sayago, MD
Related Studies
GXCA
Investigator: Lawrence Dickinson, M.D
Using Electronic Health Records to Identify Gaps in Migraine Headache Care: A Step Towards Improving Patient Outcomes
Mindfulness and Migraine: A Randomized Controlled Trial
Investigator: Sylvia Sudat, PhD